Literature DB >> 33968699

Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions.

Jing Ge1, Yiwen Chen1, Hui Yang2, Jingxue Zhao1, Dongyan Ren1, Xiaomei Wu1.   

Abstract

BACKGROUND: Our study aims to analyze the expression and significance of estrogen receptor (ER) and progesterone receptor (PR) in endometrial tissues of patients with intrauterine adhesion (IUA).
METHODS: Fifty-four patients with IUAs examined in our hospital from January 2017 to January 2019 were selected as the research object (observation group), 54 healthy women who had physical examinations during the same period were selected as the control group, and the immunohistochemical EnVision was used. Two-step and real-time fluorescent quantitative PCR methods were used to detect the expression levels of ER and PR in the endometrial tissues of the two groups of subjects.
RESULTS: The immunohistochemical test results showed that ER's expression level in the observation group was significantly higher than that in the control group, and the difference between the two groups was statistically significant (P<0.05). The difference in PR expression levels between the two groups was insignificant (P<0.05). Real-time fluorescent quantitative PCR results showed ER and PR's expression levels in the observation group were significantly higher than those in the control group, and the difference between the two groups was statistically significant (P<0.05).
CONCLUSIONS: After IUA can detect ER and PR expression, we can formulate a personalized hormone treatment plan to improve the clinical treatment effect. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Estrogen receptor (ER); immunohistochemistry; intrauterine adhesion (IUA); progesterone receptor (PR)

Year:  2021        PMID: 33968699      PMCID: PMC8102233          DOI: 10.21037/gs-21-232

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  18 in total

Review 1.  Progesterone resistance in endometriosis: origins, consequences and interventions.

Authors:  Bansari G Patel; Martin Rudnicki; Jie Yu; Yimin Shu; Robert N Taylor
Journal:  Acta Obstet Gynecol Scand       Date:  2017-06       Impact factor: 3.636

Review 2.  Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions.

Authors:  Longfa Kou; Xue Jiang; Shuyi Xiao; Ying-Zheng Zhao; Qing Yao; Ruijie Chen
Journal:  J Control Release       Date:  2019-12-09       Impact factor: 9.776

3.  Effectiveness of estrogen treatment before transcervical resection of adhesions on moderate and severe uterine adhesion patients.

Authors:  Ai-Zhen Liu; Hong-Guo Zhao; Ying Gao; Ming Liu; Bao-Zhi Guo
Journal:  Gynecol Endocrinol       Date:  2016-03-16       Impact factor: 2.260

4.  Multi-walled carbon nanotubes inhibit estrogen receptor expression in vivo and in vitro through transforming growth factor beta1.

Authors:  L Cody Smith; Santiago Moreno; Sarah Robinson; Marlene Orandle; Dale W Porter; Dipesh Das; Navid B Saleh; Tara Sabo-Attwood
Journal:  NanoImpact       Date:  2019-03-21

Review 5.  Intrauterine adhesion prevention after hysteroscopy: a systematic review and meta-analysis.

Authors:  Mae Wu Healy; Brian Schexnayder; Matthew T Connell; Nancy Terry; Alan H DeCherney; John M Csokmay; Belinda J Yauger; Micah J Hill
Journal:  Am J Obstet Gynecol       Date:  2016-05-10       Impact factor: 8.661

Review 6.  A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options.

Authors:  Christina A Salazar; Keith Isaacson; Stephanie Morris
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

7.  Androgen Receptor Expression In Endometrial Carcinoma And Its Correlation With Estrogen Receptor And Progesterone Receptor And Clinicopathological Findings.

Authors:  Maryam Nisar; Sajid Mushtaq; Usman Hassan; Noreen Akhtar; Muhammad Azma
Journal:  J Ayub Med Coll Abbottabad       Date:  2020 Apr- Jun

Review 8.  Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.

Authors:  Adriana C Rodriguez; Zannel Blanchard; Kathryn A Maurer; Jason Gertz
Journal:  Horm Cancer       Date:  2019-02-02       Impact factor: 3.869

Review 9.  Asherman's syndrome: current perspectives on diagnosis and management.

Authors:  Eva Dreisler; Jens Joergen Kjer
Journal:  Int J Womens Health       Date:  2019-03-20

10.  Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism.

Authors:  Wen-Jie Zhou; Jie Zhang; Hui-Li Yang; Ke Wu; Feng Xie; Jiang-Nan Wu; Yan Wang; Li Yao; Yan Zhuang; Jiang-Dong Xiang; Ai-Jun Zhang; Yin-Yan He; Ming-Qing Li
Journal:  Cell Commun Signal       Date:  2019-08-20       Impact factor: 5.712

View more
  2 in total

1.  Comparison of the Reproductive Outcome Between 2 and 4 mg Daily Doses of Estradiol After Hysteroscopic Adhesiolysis: A Propensity Score Matching Analysis-Retrospective Cohort Study.

Authors:  Dan-Er Qiu; Wan-Lin Zhang; Jin Liu; Fang Yang; Ye Miao; Ya-Fei Tong; Xi-Feng Xiao; Xiao-Hong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

2.  Estradiol and intrauterine device treatment for moderate and severe intrauterine adhesions after transcervical resection.

Authors:  Yun Sun; Xiuying Chen; Zhida Qian; Lili Cao; Sifeng Zhan; Lili Huang
Journal:  BMC Womens Health       Date:  2022-08-29       Impact factor: 2.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.